Ep 33 Talking About Glaucoma - 31Dec2020 DeMORAES Gus Humphrey 24-2C The Origin Story (AAC)
/TAG Episode 33 - 31Dec2020 DeMORAES Gus Humphrey 24-2C The Origin Story (AAC)
[This is the m4a (AAC) version. Starting with Episode 30, aside from minor sound quality differences, there is no longer a difference between the AAC and MP3 versions of my podcast. The additional artwork and chapter markers have been too time consuming and have not really been noticed by anyone! Enjoy the show.]
Gus DeMoraes
Intro: Welcome to Talking About Glaucoma episode #33 for December 31, 2020. I bet you're glad this year is over! I'm still digging through the vaults to post episodes like this gem and have a few more that will go live soon. Email me at podcast@iguy.org if you would like to be on the show to discuss a topic in glaucoma or if you have questions that you would like to have answered on a future episode. Check out WestCoastGlaucoma on Instagram https://instagram.com/westcoastglaucoma for some short-form videos that can also be found on my robschertzer YouTube channel. https://youtube.com/robschertzer.
In this episode, I talk with Gus DeMoraes, a frequent guest of the pod. Gus is Associate Professor of Ophthalmology at Columbia University where he serves as Medical Director of Clinical Trials. When we originally sat down to record this way back in March 2019, he had just presented some of the work he had done in collaboration with Don Hood. This has now appeared on Humphrey perimeters as the 24-2C testing strategy and is becoming a new the standard of care. It is based on reports in recent years that glaucoma damage often occurs in the macular area but missed because the standard 24-2 testing strategy only tests in 6 degree increments. These early central glaucomatous defects are often hidden between the test points. Listen in as I talk with Gus.
I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.
Outro: Talking About Glaucoma is a podcast of indeterminate frequency and duration. It’s available for free on Apple Podcasts, Spotify, Google Podcasts, PocketCasts, and many other podcast services. Please rate the podcast on Apple Podcasts, subscribe to it, and tell your friends about it, so that it can reach more listeners. Follow WestCoastGlaucoma on Instagram and Talking About Glaucoma on Facebook. Drop me a line at podcast@iguy.org with your show ideas or questions you would like to have answered on future episodes. Keep informed to prevent needless loss of vision from glaucoma, stay safe, wear a mask and get vaccinated. See you next time on Talking About Glaucoma.
—————————————————————————
About our guest:
Gus DeMoraes: https://www.columbiaeye.org/profile/cgdemoraes?profile=researcher
Relevant publications
DE MORAES CG, Sun A, Jarukasetphon R, Rajshekhar R, Shi L, Blumberg DM, Liebmann JM, Ritch R, Hood DC. Association of Macular Visual Field Measurements With Glaucoma Staging Systems. JAMA Ophthalmol. 2018 Nov 8 [Epub ahead of print]
Mavrommatis MA, Wu Z, Naegele SI, Nunez J, DE MORAES CG, Ritch R, Hood DC. Deep Defects Seen on Visual Fields Spatially Correspond Well to Loss of Retinal Nerve Fiber Layer Seen on Circumpapillary OCT Scans. Invest Ophthalmol Vis Sci. 2018;59(2):621-628
Garg A, DE MORAES CG, Cioffi GA, Girkin CA, Medeiros FA, Weinreb RN, Zangwill L, Liebmann JM. Baseline 24-2 Central Visual Field Damage is Predictive of Global Progressive Field Loss. Am J Ophthalmol. 2018;187:92-98
—————————————————————————
Production information:
This episode was recorded March 17, 2019 during the Annual Meeting of the American Glaucoma Society in San Francisco using two Shure SM58 microphones with a Marantz PMD661 digital recorder. Mixing and sound levelling were finally completed December 30, 2020 on an HP Spectre x360 laptop using Hindenberg Journalist Pro software and Flux Software sound processing. Narration was overdubbed using an Audio-Technica ATR2100-USB.
Opinions expressed in this podcast are those of the speakers and are not intended to be taken as the standard of care for glaucoma treatment. Please always weigh the complete clinical picture and involve patients with any decisions in their care.
Robert M Schertzer, MD, MEd, FRCSC
podcast@iguy.org
Twitter - https://twitter.com/robschertzer
or http://iguy.tv/twitter
Blog - http://wholelottarob.com
or http://iguy.tv/blog
Facebook - https://facebook.com/talkingaboutglaucoma
Office website - https://westcoastglaucoma.com
or http://iguy.tv/office
YouTube channel - https://youtube.com/robschertzer
Instagram - https://instagram.com/westcoastglaucoma
Theme music “Middle East Gold” ©Daniel Schertzer 2010 and published by Les Prods DOSWA Enr
© 2020 DOSWA Prods Enr/Robert M Schertzer MD. MEd, FRCSC
—————————————————————————
iTunes Subtitle:
A talk with Gus DeMoraes on the development of the Humphrey 24-2C testing strategy.
iTunes Summary:
In this episode, I talk with Gus DeMoraes, a frequent guest of the pod. Gus is Associate Professor of Ophthalmology at Columbia University where he serves as Medical Director of Clinical Trials. When we originally sat down to record this way back in March 2019, he had just presented some of the work he had done in collaboration with Don Hood. This has now appeared on Humphrey perimeters as the 24-2C testing strategy and is becoming a new the standard of care. It is based on reports in recent years that glaucoma damage often occurs in the macular area but missed because the standard 24-2 testing strategy only tests in 6 degree increments. These early central glaucomatous defects are often hidden between the test points.
I'm Rob Schertzer, a Vancouver, Canada based glaucoma specialist, podcaster and HealthIT expert, and we're...talking about glaucoma.